logo
Adderall shortage continues to impact millions of Americans living with ADHD

Adderall shortage continues to impact millions of Americans living with ADHD

Yahoo24-02-2025
Living without regular access to the commonly prescribed ADHD medicine Adderall is "like living neck deep in cold molasses," said one Reddit user on a support forum for people living with attention-deficit/hyperactivity disorder. On the forum, the same user shared that the difficulties of filling prescriptions two years after the U.S. first reported shortages has caused a "depressing reality of very limited executive function can sometimes be a crushing weight that's hard to get out from underneath."
Unfortunately, as the shortage of Adderall announced by the Food and Drug Administration in October 2022 continues, more Americans have been feeling that "crushing weight." These delays have been attributed to supply chain and manufacturing issues, high prescription rates spurred by the growth in telemedicine, and limited production quotas. As many as 15.5 million adults and 7 million children navigate life with ADHD and are affected by these shortfalls daily.
ADHD Advisor examined data from the Drug Enforcement Administration and other sources to explore the rise in prescription stimulants and why this shortage is so concerning.
Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists, told PBS that he understands the frustration of the shortfall. "Patients need a new prescription every 30 days. You can't get a 90-day supply. You can't even pay cash for a longer supply if you want to." Prescriptions cannot be transferred between pharmacies if stock is out, and a doctor must reissue a new script.
This monthly relay of administrative hurdles to secure medication is trying for people with ADHD who often have difficulties with "executive functioning," a type of focus needed for things like making plans, adapting to new ones, and solving problems.
Russell Barkley, a psychologist, told STAT News that ADHD is the "most treatable chronic health disorder in the world," saying that stimulant drugs relieve 80 to 90% of patients of ADHD symptoms. Stimulant medication is often the first line of treatment for people with ADHD, and they're also sometimes used for binge eating and narcolepsy disorders.
Without these medications—like Adderall, which releases extra dopamine and norepinephrine to the brain—people with ADHD are more likely to experience adverse outcomes, like impaired social and emotional behaviors, increased substance or alcohol abuse, accidents, or premature death.
Between 2012 and 2022, stimulants dispensed in the U.S. increased by 57.9%, according to a report commissioned by the DEA. Three times more stimulants were dispensed for people aged 31 to 40 and those 71 to 80 years old. In 2022, women also received more stimulants than men for the first time since 2012.
According to a report issued by the Centers for Disease Control and Prevention, nearly a third of adults diagnosed with ADHD treated it with stimulants in 2023, but more than 7 in 10 of them reported difficulty filling prescriptions due to unavailability.
The classification of stimulants is a significant variable in the domino effect that caused the ongoing shortages. The FDA approves the use of these drugs to treat ADHD; however, the DEA classifies stimulants as Schedule II medications since the ingredients in these drugs create a high potential for abuse and dependence.
These tightly regulated drugs are overseen by the DEA, which decides how many Schedule II drugs can be produced each quarter and allocates production quotas for each manufacturer.
But if there's a hiccup in production, a telehealth company that offers prescriptions shuts down, or a manufacturer encounters labor shortages, the FDA and DEA cannot quickly redirect unused quotas. According to a joint letter issued in August 2023, these government bodies cannot require pharmaceutical companies to "make a drug, make more of a drug, or change the distribution of a drug."
Compounding this issue, the rates of stimulants prescribed by telehealth services rose from 1% in March 2020 to 10% in April 2020 after lawmakers permitted virtual prescriptions for Schedule II drugs when patients couldn't see their doctor face-to-face during the COVID-19 pandemic. For ADHD patients, telehealth prescriptions save time since the Schedule II classification means they must meet with their prescriber every 30 days to get the next month's supply.
Though stimulants prescribed through telemedicine have declined steadily since 2020, their use continues to be higher than pre-pandemic levels, indicating a continued need by a sizable population. This telehealth flexibility may soon be revoked by the end of 2024, however, as lawmakers consider ways to curb drug misuse and addiction.
In September 2024, the DEA was finally able to increase quotas for the production of other drugs that help curb ADHD. Interventions like these help ease the demand and allow patients to be diagnosed responsibly and through legitimate means.
Yet, patients who still struggle to get their ADHD prescriptions filled desperately seek alternative means to acquire medication, even resorting to questionable asks on dating apps. While these methods may sometimes provide the patients access to the medicines they need, patients should be wary. The CDC warns that counterfeit pills in illegal drug markets are prevalent and could unexpectedly contain substances like fentanyl that significantly increase the risk of a patient overdosing.
To navigate future disruptions to ADHD medicine, the CDC recommends scheduling an appointment with prescribers as soon as possible before running low on supply. Patients can also troubleshoot with their health care provider and pharmacist.
Reddit users on an ADHD forum suggest using independent pharmacies that may have fewer stock issues than mainstream retailers or asking the prescriber for higher doses that patients can then lower the dosage on personally—only if the medicine is safe to cut. One user suggested physically bringing a paper prescription to pharmacies to see if they can fill it. Patients can also switch to less common ADHD medication. While these are all strategies patients have used, please seek professional advice from a qualified clinician to address your particular concerns.
Ideally, the future holds expanded treatment for people with ADHD apart from just stimulants. The FDA stated that it supports the development of alternative treatments, such as nonstimulant drugs or nondrug options like game-based digital therapies for children to improve their attention.
Story editing by Carren Jao. Additional editing by Kelly Glass. Copy editing by Tim Bruns.
This story originally appeared on ADHD Advisor and was produced and distributed in partnership with Stacker Studio.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Parents' Experiences: Strattera vs Adderall for Young Kids
Parents' Experiences: Strattera vs Adderall for Young Kids

Time Business News

time2 hours ago

  • Time Business News

Parents' Experiences: Strattera vs Adderall for Young Kids

When a child is diagnosed with ADHD, parents often face the difficult decision of choosing the most suitable treatment. Two of the most commonly prescribed medications are Strattera vs adderall. While both aim to help manage ADHD symptoms, they differ significantly in how they work and affect children. Understanding how other parents perceive these medications can provide valuable insight for those navigating this challenging decision. When it comes to treating anxiety and depression, finding the right medication can be a complex decision. Two commonly prescribed SSRIs are Lexapro vs zoloft, each with unique effects on mood and potential side effects. While both medications work by increasing serotonin levels in the brain, they may differ in how quickly they act or how well they're tolerated by different individuals. Factors like your medical history, other medications, and potential side effects should be considered. Consulting with a healthcare provider is essential to determine which option aligns best with your personal needs and treatment goals. Strattera is a non-stimulant medication that works by increasing levels of norepinephrine in the brain. Unlike Adderall, which is a stimulant, Strattera does not have immediate effects and may take several weeks to show benefits. Adderall, on the other hand, is a fast-acting stimulant that affects dopamine and norepinephrine levels, leading to a quicker response in terms of symptom management. These fundamental differences lead to varying experiences among parents and children. Many parents approach ADHD medications with caution, especially when the child is young. One common concern is the fear of personality changes or emotional blunting. Parents who chose Strattera often mention that they preferred starting with a non-stimulant to avoid the potential for stimulant-related side effects, such as sleep disturbances or appetite suppression. Others opted for Adderall because of the immediate need for symptom control, especially if behavioral issues were affecting school performance. Parents who have used Strattera for their children often describe the experience as a slow but steady journey. It typically takes several weeks to notice any improvement, which can test a parent's patience. However, many appreciate the subtle nature of the changes. One mother of a seven-year-old mentioned that her son became 'more thoughtful and less reactive' over time, without feeling sedated or overly quiet. Another parent shared that Strattera helped improve her daughter's emotional regulation and focus in school, with fewer emotional outbursts at home. However, the slower onset of action also proved frustrating for some. A few parents noted that their children did not respond to Strattera even after the full trial period, and they had to eventually switch to a stimulant. Side effects such as stomachaches, mood swings, or fatigue were also reported by some families, although they often resolved after dosage adjustments. Parents who opted for Adderall often report quicker results, sometimes within the first day or week of treatment. Many noted dramatic improvements in attention span, classroom behavior, and overall school performance. A father of a six-year-old shared that his son 'could finally sit through a lesson and follow instructions,' something that seemed impossible before starting Adderall. Others echoed this sentiment, saying their child was more engaged and less impulsive, both in school and at home. Despite its effectiveness, Adderall's side effects were a significant concern for many parents. Common issues included appetite suppression, difficulty sleeping, and increased irritability, particularly when the medication wore off in the evening. Some children experienced emotional crashes or became overly focused, leading to rigidity in thinking or behavior. One parent described how her daughter became 'laser-focused but anxious,' prompting a reevaluation of the dosage and timing. Many parents emphasized that medication, whether Strattera or Adderall, was just one part of a broader ADHD management plan. Behavioral therapy, consistent routines, diet changes, and strong communication with teachers were often mentioned as essential components. Parents appreciated doctors who took a holistic approach and encouraged regular check-ins to monitor the child's progress and adjust treatment accordingly. Some parents also found success in switching between medications or combining low doses of both under medical supervision. For example, a mother described starting her son on Strattera and later adding a small dose of Adderall to target specific school hours, which helped reduce side effects while maintaining effectiveness. Navigating ADHD treatment is not just a medical decision—it's an emotional journey. Parents often expressed feelings of guilt, worry, and self-doubt, especially during the early stages of treatment. Seeing improvements in their child's ability to function and succeed brought relief and even joy. At the same time, dealing with side effects or trial-and-error periods was emotionally draining. Several parents mentioned the importance of parent support groups, either in person or online, where they could share experiences and receive guidance. Children, too, were affected emotionally by their treatment experience. Some became more confident as they gained control over their behavior and received positive feedback from teachers. Others struggled with the stigma of taking medication or experienced self-esteem issues related to side effects. Open conversations, reassurance, and involving the child in age-appropriate decisions helped many families navigate these challenges. Every child with ADHD is unique, and so are their responses to medications like Strattera and Adderall. The experiences of parents reveal that while some children thrive on one medication, others may struggle. The key is working closely with healthcare providers, being patient during the trial period, and focusing on the child's overall well-being rather than just symptom control. Whether choosing Strattera for its gradual, non-stimulant benefits or Adderall for its quick symptom relief, parents play a crucial role in advocating for their child's needs and ensuring a balanced, personalized treatment approach. Their voices remind us that the journey may be complex, but with support and persistence, improvement is possible. TIME BUSINESS NEWS

Wendy's wins an honor no restaurant wants
Wendy's wins an honor no restaurant wants

Miami Herald

time3 hours ago

  • Miami Herald

Wendy's wins an honor no restaurant wants

The pandemic and its afterburn decimated restaurants. Only one sector has been a bright spot: fast food. Fast-food joints like McDonald's, Chick-fil-A, Wendy's, and Taco Bell are still popular, thanks to convenience and value. We Americans love our fast food, but that convenience comes at a cost not reflected in the price tag. Don't miss the move: Subscribe to TheStreet's free daily newsletter When you look at the nutritional data from many of the most popular fast-food chains, what you see is alarming, especially when you consider that 19.7% of children ages 2-19 years in the U.S. are obese. But the problem isn't just calories. Fast food contains fat, sodium, and added sugar that contribute to serious health problems like heart disease and Type 2 diabetes. Those fries, Frostys and bacon-laden burgers are definitely delicious, but a single meal from a fast-food chain often contains more calories than a person needs for a whole day. If you're trying to decide between a handful of your favorite spots, you might want to check out World Atlas' recent comparison of fast-food chains. They found that when it comes to unhealthy menu items, a couple of chains stand out from the rest. In their ranking, World Atlas looked at the nutritional data from nearly a dozen popular menu items. The survey factored in calories, saturated fat, sodium, and sugar. According to the findings, Wendy's is one of the unhealthiest chains in the U.S., but the legacy fast-food chain has plenty of company. Sonic Drive-In, Popeyes, McDonald's, Five Guys, Dairy Queen, and Carl's Jr. are also on the list of the worst for you. While Wendy's has made an effort to use and promote fresh ingredients, like its "Fresh never frozen beef" promise, and offers a variety of green salads prepared daily, its signature sandwich, the Baconator, rings in at more than 900 calories. When packaged with an order of medium fries and a medium Frosty, the tally jumps to than 1,600 calories. Related: McDonald's Snack Wrap causes alarming shortage The fat and sodium levels in this one meal are above daily recommended limits, yet Wendy's marketing embraces indulgence. Slogans like "You know you want it" and "Baconator. Resistance is futile," give off a "We know you can't help yourself" kind of energy. It's hard to beat the quick-service convenience and the fact that the Wendy's Baconator meal is just $12 (where I live in Nevada). A similar meal - bacon cheeseburger, fries, chocolate shake - at a sit-down restaurant like Red Robin will set you back more than $24. The bottom line is that fast-food chains are thriving, even as concerns around Americans' overall health grow. The one thing all the names on the unhealthiest list have in common is fiercely loyal fan bases, and appearing on lists like World Atlas' doesn't appear to hurt business much. Wendy's posted $2.9 billion in sales Q1 2025, down only slightly from the same time in 2024. Quick-service restaurants, including fast food chains, are popular and profiting because they offer value pricing and digital ordering and convenience. Customers also rate fast-food restaurants higher in terms of satisfaction than they do full-service restaurants. The American Customer Satisfaction Index (ACSI) 2025 report indicates that customer satisfaction with quick-service restaurants is higher than that of full-service restaurants. It can also be difficult for healthier restaurant chains to compete with the fast service and extended hours offered by national chains. So, even though healthier chains like Sweetgreen and Cava are popular in urban markets, traditional fast-food brands still dominate everywhere else. Turns out we want our food fast and cheap, no matter how many calories are in the bag. Related: McDonald's secures honor no restaurant wants The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Canned Fruit Recall Sparks Nationwide Warning to Customers
Canned Fruit Recall Sparks Nationwide Warning to Customers

Newsweek

time3 hours ago

  • Newsweek

Canned Fruit Recall Sparks Nationwide Warning to Customers

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. W.W. Industrial Group is recalling Parashore brand pear slices in juice due to fears the product may contain elevated levels of lead and cadmium. Newsweek reached out to the company via phone Wednesday for comment and left a voicemail. Why It Matters Elevated levels of lead and cadmium can cause significant health problems, particularly among infants and children. The recall adds to a growing list of high-profile food safety actions, emphasizing the ongoing importance of vigilant federal oversight and thorough product testing to protect public health. Lead and cadmium are both toxic metals that can enter the food supply from environmental sources, such as contaminated soil or industrial byproducts. According to the U.S. Food and Drug Administration (FDA), lead exposure poses particular risks to young children, whose developing brains are highly susceptible to neurotoxic effects. Elevated lead intake in early childhood has been linked to long-term issues affecting learning and behavior. Cadmium contamination can arise from soil composition, industrial activities and certain manufacturing processes. Prolonged exposure to cadmium, especially at levels above the FDA's interim reference level, can affect kidney function and increase the risk of bone demineralization. While it is not possible to completely prevent cadmium from entering the food supply, manufacturers are legally required to minimize and monitor such risks. Numerous recalls have been initiated in 2025 due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the FDA, the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. What To Know In the FDA alert, the recalled sliced pears were distributed throughout grocery outlet stores in California and other locations across the United States. The products were sold in a 15-ounce can with a UPC number of #704817164237. "The specific lot found positive for heavy metals was Lot 3700/01172 6122J, Prod: 02/19/2024, Best by 2/19/2027," the FDA warns. The agency adds that there had been no reported illnesses related to the recall as of Tuesday. What People Are Saying The FDA alert, in part: "The heavy metal contamination was discovered via sampling by the Maryland Department of Health which is part of the FDA Laboratory Flexible Funding Model program. The company has recalled the products and is continuing an investigation to determine cause." What Happens Next Customers who have purchased the recalled pear slices are urged to throw them away or return the product to the original place of purchase for a full refund, the FDA says. People with additional questions can contact W.W. Industrial Group via phone at 516- 676-9188 from 10 a.m. to 4 p.m. ET weekdays.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store